Talphera, Inc. (TLPH) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Telfera Second Quarter 2025 Financial Results Conference call. This call is being webcast live via the events page of the Investors section of Telfera's website at .telfera.com. You may listen to a replay of this webcast by going to the Investors section of Telfera's website. I would now like to turn the call over to Rafi Azadorian, Telfera's Chief Financial Officer. Thanks, Andrew, and thank you for joining us on the call today. Today we announced our Second Quarter 2025 Financial Results and Associated Business Updates in a Press Release. With me today are Vince Angati, our Chief Executive Officer, and Dr. Shaquille Aslam, Telfera's Chief Medical Officer. Before we begin, I want to remind listeners that during this call we will likely make within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Telfera. Please refer to our press release in addition to the company's periodic, current, and annual reports filed with the Securities and Exchange Commission for a discussion of the risks associated with such forward-looking statements. These documents can be found on our website within the Investors section. I'll now hand the call to Vince. Thanks Rafi. Good afternoon and thank you to everyone joining our call today. We're excited about the progress made this past quarter, specifically in the acceleration of the Nephro Study enrollment. At the end of last year, upon the announcement of Dr. Shaquille Aslam becoming the Chief Officer of Telfera, we embarked on a restructuring of the Nephro clinical study, which included changing the target profile of our clinical sites, approaching the FDA with various study protocol changes, including the reduction of t...